164 results
Page 7 of 9
8-K
EX-99.1
8e7u5b13
11 Oct 06
Discovery Labs Announces Topline Results of Surfaxin® Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12:00am
8-K
EX-99.1
kqs7v
5 Apr 06
Discovery Labs Receives Second Approvable Letter from FDA
12:00am
8-K
EX-99.1
caxutqh
30 Jan 06
Other Events
12:00am
8-K
EX-10.1
whskyven 8k
3 Jan 06
Represents strategic decision to control manufacturing of Surfaxinâ and SRT pipeline
12:00am
8-K
EX-99.1
0rraqsqnlbz6wjh
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
4of0pd
21 Oct 05
FDA Accepts Discovery Labs’ Complete Response to
12:00am
8-K
EX-99.1
1sgnuw
9 Sep 05
Discovery Labs Completes Pilot Phase 2 Study of Investigational Drug Aerosurf™, its Aerosolized Surfactant Delivered via Nasal CPAP
12:00am
8-K
EX-99.1
dakmgeq pddr8y
1 Aug 05
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am